Your browser doesn't support javascript.
loading
Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Mijuskovic, Martina; Saunders, Edward J; Leongamornlert, Daniel A; Wakerell, Sarah; Whitmore, Ian; Dadaev, Tokhir; Cieza-Borrella, Clara; Govindasami, Koveela; Brook, Mark N; Haiman, Christopher A; Conti, David V; Eeles, Rosalind A; Kote-Jarai, Zsofia.
Afiliação
  • Mijuskovic M; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Saunders EJ; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Leongamornlert DA; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Wakerell S; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Whitmore I; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Dadaev T; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Cieza-Borrella C; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Govindasami K; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Brook MN; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90015, USA.
  • Conti DV; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90015, USA.
  • Eeles RA; Oncogenetics, Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Kote-Jarai Z; The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Br J Cancer ; 119(1): 96-104, 2018 07.
Article em En | MEDLINE | ID: mdl-29915322
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Nucleares / Proteínas de Ciclo Celular / Proteína BRCA2 / Proteínas Mutadas de Ataxia Telangiectasia Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Nucleares / Proteínas de Ciclo Celular / Proteína BRCA2 / Proteínas Mutadas de Ataxia Telangiectasia Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido